Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine meds. Is it working?

harma companies vying for a piece of the lucrative migraine market have gone all-in on marketing. They've turned to Olympic athletes and Hollywood stars to pitch recently approved brands in TV commercials and on social media.

But is the message sinking in with patients? Apparently not yet, a new survey from Phreesia Life Sciences suggests.

Nearly half of the more than 4,000 migraine patients polled in July 2021 said they couldn’t recall a single brand name when asked about preventive migraine drugs. The most recognized brand? Topamax, which won FDA approval for migraine way back in 2004.